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In addition to a fundamental role in cellular bioenergetics, the purine nucleotide adenosine
triphosphate (ATP) plays a crucial role in the extracellular space as a signaling molecule. ATP
and its metabolites serve as ligands for a family of receptors that are collectively referred
to as purinergic receptors. These receptors were first described and characterized in the
nervous system but it soon became evident that they are expressed ubiquitously. In the
immune system, purinergic signals regulate the migration and activation of immune cells
and they may also orchestrate the resolution of inflammation (1, 2). The intracellular signal
transduction initiated by purinergic receptors is strongly coupled to Ca2+-signaling, and
co-ordination of these pathways plays a critical role in innate immunity. In this review, we
provide an overview of purinergic and Ca2+-signaling in the context of macrophage phe-
notypic polarization and discuss the implications on macrophage function in physiological
and pathological conditions.
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PURINERGIC RECEPTORS IN MACROPHAGES
Purinergic receptors are divided into P1 and P2 receptors. The
adenosine receptors are referred to as P1 receptors. P2 receptors
are the receptors for adenosine triphosphate (ATP) and can be
further subdivided into metabotropic P2Y receptors, which are
G-protein-coupled receptors and ionotropic P2X receptors, which
are cation-selective ion channels. Macrophages express a wide vari-
ety of P2X and P2Y receptors; analysis of mouse macrophages
using a variety of techniques indicates the presence of P2X4, P2X7,
P2Y1, P2Y2, P2Y4, and P2Y6 receptors (3). Additionally, the expres-
sion of P2Y12 receptor has been reported in microglia (4) and
macrophages (5). Historically, macrophages were also thought
to express an additional ATP-sensitive large conductance channel
termed P2Z receptor (6). However, this receptor was later shown
to be P2X7 by Surprenant et al. (7).
RELEASE OF ATP AND OTHER NUCLEOTIDES INTO THE EXTRACELLULAR
SPACE
Cytosolic ATP can be secreted through the release of ATP-loaded
vesicles or through the activation of large conductance chan-
nels (8). A variety of inflammation-related biological processes
result in ATP release from cells, and macrophages respond to this
extracellular ATP rapidly. Elegant studies by Ravichandran and
colleagues have shown that cells undergoing apoptosis release ATP
as a find-me signal that attracts phagocytes (9). In the case of dying
cells, the release of ATP and other nucleotides is accomplished
through Pannexin 1, a hemi-channel that is activated through
caspase-dependent cleavage (10). Interestingly, monocytes stimu-
lated with pathogen-associated ligands or danger molecules, such
as uric acid can secrete ATP, which may execute an autocrine sig-
nal that results in the activation of inflammasomes and secretion
of IL-1β and IL-18 (11). Moreover, the activation of the com-
plement cascade has also been shown to elicit ATP efflux from
macrophages and subsequent autocrine activation of the NLRP3
inflammasome (12).
THE FUNCTION OF P2Y RECEPTORS IN MACROPHAGES
In 1989, Dubyak and colleagues showed that treatment of
macrophages with extracellular ATP elicits elevations in intra-
cellular Ca2+ in a wide variety of myeloid cells but not in lym-
phocytes. These Ca2+-elevations correlated with the hydrolysis
of inositol phospholipids suggesting that the ATP receptors were
Gq-coupled (13). Over the course of the last two decades, it has
become clear that the P2Y receptors on macrophages are Gq and
Gi/o-coupled and that they perform a critical function in ATP-
responsive chemotaxis. For instance, the chemotaxis of cultured
microglia in response to extracellular ATP was shown to be depen-
dent on Gi/o-coupled P2Y receptors by Honda et al. (14). This
receptor was later identified as P2Y12. Microglia deficient in P2Y12
fail to polarize and migrate toward an ATP source in vitro and is
unable to extend their processes toward sites of brain damage in
mice (4). On a related note, microglial phagocytosis is triggered
by UDP that is released by damaged neurons and is dependent on
P2Y6 receptors (15). In monocytes and macrophages, P2Y2 plays
a crucial chemotactic role in locating apoptotic cells releasing ATP
(9). This study used a murine air-pouch model to demonstrate
that cell supernatants from apoptotic cells were able to recruit
monocytes and macrophages in vivo and that this recruitment
was diminished in mice lacking the P2Y2 receptor. In models of
lung inflammation, P2Y2 plays a prominent role in the chemo-
taxis of dendritic cells and eosinophils. Moreover, mice deficient
in the P2Y2 receptor show reduced airway inflammation in lung
inflammation models where ATP has been shown to accumulate
in the airways (16). Macrophages navigating in a gradient of C5a
secrete ATP and use a purinergic feedback loop that involves P2Y2,
P2Y12, and P1 receptors to migrate (5). However, ATP-triggered
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Table 1 | Purinergic receptors andTRP channels in macrophages.
Activation Downstream signaling Cellular function Disease model phenotype after targeting
A1 Adenosine Gi-coupled
A2A Adenosine Gs-coupled Augment M2 polarization (63) Extensive tissue damage and prolonged inflammation (67)
Agonists induce alleviation of neural inflammation (70)
A2B Adenosine Gs/Gq-coupled (?) Augment M2 polarization (63) Gene deletion exacerbates lung inflammation (71)
Increased mortality in a sepsis model (72)
A3 Adenosine Gi-coupled Downregulation of inflammatory
cytokines (65, 66)
Reduced arthritis using agonists (67)
P2X4 ? ? ? ?
P2X7 1 mM ATP Non-selective cation
flux
Activation of NLRP3 and
caspase-1
Resistance to contact allergen sensitivity (23)
Lysosomal secretion of
cathepsins (27)
Reduced GVHD (24)
Resistant to pulmonary inflammation (25)
P2Y2 ATP (9) ? Dendritic cell chemotaxis (9) Reduced airway inflammation (16)
P2Y4 ? ? ? ?
P2Y6 UDP (15) Gq-coupled? Microglial phagocytosis (15)
P2Y12 ATP (4) Gi/o-coupled (14) Microglial chemotaxis (4)
TRPC1 ? Ca2+-influx (42) Unconventional secretion (42)
TRPV2 ? Ca2+-influx (39) Initiation of phagocytosis (39)
TRPM2 ROS Ca2+-influx (38) Chemokine secretion (38) Reduced neutrophil infiltration and intestinal inflammation (38)
TRPML1 ? Lysosomal Ca2+-release
(42)
Focal exocytosis during
phagocytosis (42)
Decreased bacterial clearance
?, Unknown.
chemotactic differences in M1 and M2 macrophages have not
been explored and the functional contribution of various P2Y
receptors in macrophage phenotypes remains uncharacterized
(Table 1).
THE FUNCTION OF P2X RECEPTORS IN MACROPHAGES
In comparison to P2Y receptors, the P2X receptors have a signif-
icantly lower affinity for ATP but their ability to respond to ATP
is influenced by the ionic conditions. In the case of P2X7, replace-
ment of Na+ with K+ greatly increases the responsiveness to ATP
suggesting a physiological role in damaged tissues with altered
ionic conditions (17). Activation of P2X7 by high concentrations
of ATP mediates caspase-1-dependent cell death accompanied by
the release of proinflammatory cytokines, such as IL-1β and IL-18.
This process is greatly potentiated in macrophages activated by LPS
(18). The processing of IL-1β and IL-18 by caspase-1 is followed
by their unconventional secretion with or without accompanying
pyroptosis, a caspase-1 mediated pathway of inflammatory cell
death. These mechanisms appear to be greatly potentiated by the
influx of extracellular Ca2+ through the P2X7 channels (19). Pre-
cisely how Ca2+ modulates the machinery mediating the secretion
of IL-1β is not clear. Activation of P2X7 also induces membrane
blebbing and activation of Rho-effector kinases but whether the
influx of Ca2+ is essential for these processes is also not clear. Con-
comitantly, P2X7 is thought to regulate inflammasome-dependent
activation of caspase-1 by mediating K+ efflux (20) and through
the potentiation of an NFκB-driven transcriptional program (21).
In a related process, P2X7 has been shown to control the secretion
of MHC class II-containing exosomes in NLRP3-dependent but
caspase-1-independent manner (22).
Due to the crucial role played by P2X7 in the regulation of the
NLRP3 inflammasome, it has been implicated as a molecular target
in a large variety of inflammatory diseases (Table 1). Mice deficient
in P2X7 are not sensitized to contact allergens and fail to release
IL-1β in response to LPS and ATP (23). This study suggests that the
ligation of P2X7 by ATP is crucial for initiating skin inflammation.
Similarly, P2X7 expression on antigen presenting cells appears to
have a major impact on graft-versus-host disease (GVHD) (24).
How P2X7 affects antigen processing and presentation is not clear
yet. The P2X7-deficient mice have also been shown to be highly
resistant to pulmonary inflammation induced by exposure to ciga-
rette smoke (25). In the case of intestinal inflammation, mast cells
expressing P2X7 have been shown to play a central role in initiat-
ing the inflammatory cascade (26). In this case, it seems likely that
the influx of Ca2+ through P2X7 potentiates the degranulation of
mast cells. A similar role for P2X7-mediated potentiation of lyso-
somal secretion of cathepsins has been reported in a mouse model
of arthritis (27). Recently, it was discovered that monocytes from
patients afflicted with Behcets disease, a severe auto-inflammatory
disorder, have increased expression of P2X7 (28). Recent stud-
ies have also implicated P2X7 in the modulation of adaptive
immunity through the control of antigen presentation on MHC
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class I molecules (29). In addition to P2X7, macrophages also
express P2X1 channels but the functional significance is not yet
clear (30). Although M1 macrophages are more efficient at ATP-
induced secretion of IL-1β (31), no significant differences in the
expression levels of P2X7 have been noted. It has been suggested
that P2X7 activation is decoupled from IL-1β regulation in M2
macrophages (31).
CALCIUM CHANNELS IN MACROPHAGES
As non-excitable cells,macrophages rely on Ca2+-permeable chan-
nels that are not gated by voltage. In addition to P2X channels,
macrophages express the store-operated Orai channels and some
members of the transient receptor potential (TRP) channel super-
family. The regulation and function of these ion channels remains
a mystery and is an emerging topic of significance to inflammation
(Table 1).
ORAI CHANNELS IN MACROPHAGES
Historically, the elevations of intracellular Ca2+ in macrophages
were first observed in response to platelet-activating factor (PAF)
(32). In accord with the classic store-operated Ca2+-entry, PAF
first elicited the mobilization of intracellular Ca2+ stores through
a Gq-coupled pathway. The emptying of the ER stores was then
followed by the opening of the Ca2+-permeable channels in the
plasma membrane, the so-called CRAC channels (33). For almost
two decades, the identity of CRAC channels remained a mystery
but we now know their molecular identities as Orai channels (34).
Recent discoveries have unraveled the regulatory mechanisms of
Orai channels but their functional role in macrophage biology
remains undefined. Some observations have linked store-operated
Ca2+ response to the production of reactive oxygen species (ROS)
in macrophages but definitive work and mechanistic insights have
not been forthcoming (35). The Ca2+-influx necessary for the
engulfment of apoptotic cells by macrophages is thought to be
mediated by Orai channels and genetic studies in Caenorhabdi-
tis elegans support this notion (36) but how these channels are
activated when macrophages encounter apoptotic cells is not clear
and the precise role of Ca2+ in the engulfment process has not
been clarified. Since P2Y receptors can be Gq-linked, the sub-
sequent depletion of Ca2+ stores through IP3 receptors should
result in activation of Orai channels. Whether this actually occurs
and whether Ca2+-influx through Orai channels is critical for the
cellular outputs of P2Y receptor stimulation is not yet clear.
TRP CHANNELS IN MACROPHAGES
The 28 members of TRP channel superfamily are subdivided
into TRPC (seven members), TRPV (six members), TRPM (eight
members), TRPML (three members), TRPP (three members),
and TRPA (one member) families (37). TRP channels are cation-
selective channels that are weakly voltage-sensitive and diversely
gated by temperature, mechanical force, electrophiles, ligands, and
internal cues, such as membrane composition and pH. Recent
reports have highlighted the potent functional impact of these
channels in macrophages. In monocytes lacking TRPM2, the
Ca2+-influx in response to ROS is diminished and the cells are
unable to produce chemokines necessary for the recruitment of
other cells (38). In a mouse model of intestinal inflammation,
ulceration and neutrophil infiltration were significantly attenuated
in mice lacking TRPM2 (38).
Transient receptor potential channels have also been shown to
play a major role in phagocytosis. Macrophages lacking TRPV2 are
deficient in the triggering of phagocytosis when they encounter
zymosan and IgG opsonized particles (39). Whether this func-
tion of TRPV2 is coupled to the influx of Ca2+ or other cations is
not entirely clear but abnormalities in cytoskeletal rearrangements
during phagocytosis were observed and the cells were also found
to be deficient in chemotaxis. Mice lacking TRPV2 respond poorly
when challenged with Listeria monocytogenes. They show increased
mortality and greater bacterial load in their organs (39). During
phagocytosis, macrophages replenish their membranes through a
process termed focal exocytosis. This process was thought to be
independent of Ca2+ (40), but for the phagocytosis of large par-
ticles, the process requires the activity of TRPML1 (41). Xu and
colleagues have shown that TRPML1 is a lysosomal channel that is
essential for the phagocytosis of large particles. Through the com-
bined use of electrophysiology and live-cell imaging, authors show
convincingly that TRPML1 mediates the release of lysosomal Ca2+
at the site of membrane uptake during large particle phagocytosis.
Recently, TRPC1 has been shown to play a role in restraining
the unconventional secretion of IL-1β (42). Secretion of IL-1β is
greatly potentiated after the degradation of TRPC1 by caspase-11
and macrophages lacking TRPC1 show increased secretion of IL-
1β in response to inflammatory stimuli. The precise mechanism
through which TRPC1 regulates this unconventional secretion
machinery is not yet clear.
COUPLING OF PURINERGIC AND CALCIUM SIGNALING IN
MACROPHAGES
Extracellular ATP induces Ca2+ elevations in myeloid cells through
the activation of Gq-coupled P2Y receptors and Ca2+-permeable
P2X channels. P2Y receptors have a higher affinity for ATP and can
elicit Ca2+ mobilization from the intracellular stores at low micro-
molar concentrations of extracellular ATP (13). In contrast, the
P2X channels open at millimolar concentrations of ATP and medi-
ate the influx of extracellular Ca2+ and other cations (43). Notably,
the mobilization of Ca2+ stored in the endoplasmic reticulum is
not sufficient for the activation of caspase-1 and secretion of IL-
1β. When cells are stimulated with ATP in extracellular medium
that is depleted of Ca2+, IL-1β secretion is nearly abolished (19).
These observations indicate that activation of caspase-1 requires
a sustained and more intense rise in intracellular Ca2+, which
can be mediated by the activation of P2X7 channels but not P2Y
receptors.
An alternative explanation for differential requirements of
Ca2+ stores and Ca2+-entry in the activation of caspase-1 involves
the efflux of K+ through the activated P2X7 channels. In this
model, a concomitant efflux of K+ is necessary for the activa-
tion of caspase-1 and the rise in intracellular Ca2+ without K+
efflux is insufficient (44). In any case, although the activation of
P2Y receptors by low concentrations of ATP is insufficient to acti-
vate caspase-1, the resulting Ca2+ oscillations have been shown
to promote the transcription of proinflammatory cytokines such
as IL-6 (45). The relative contributions of P2X and P2Y receptors
in nucleotide-induced Ca2+-signaling have not been adequately
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defined but the use of knockout mice has provided useful insights
into this complex aspect of inflammation (46). In myeloid cells,
Ca2+-dependent activation of PKC plays a pivotal role in the NFκB
pathway (47) and the cellular outputs at the site of inflammation
are thus likely to be shaped by the purinergic microenvironment.
Even in the absence of purinergic signals, Ca2+ stores can be
mobilized by Toll-like receptors through the activation of tyro-
sine kinases and phospholipase C (48), but the presence of ATP
in the microenvironment likely functions as a potent amplifying
mechanism for inflammatory processes.
In addition to the regulation of proinflammatory gene expres-
sion and cytokine secretion, Ca2+-signaling plays a major role in
phagosome maturation. This link is exploited by the internalized
mycobacterium for immunoevasive block of phagosome matura-
tion (49). Although the role of Ca2+ in phagosome maturation
is incompletely defined, it is clear that the lysosomal synaptotag-
min VII, a Ca2+-sensitive protein, is essential for the fusion of
lysosomes with phagosomes (50, 51). Ca2+-influx is also essential
for the engulfment of apoptotic cells and a subsequent anti-
inflammatory response (36). Macrophage phenotypic polarization
results in significant differences in the execution of phagocytosis
and phagosome maturation but the associated differences in the
role of purinergic and Ca2+-signals between differentially polar-
ized macrophages remain undefined (52). Ca2+-influx has also
been shown to be essential to maintain the leading-edge structure
in migrating macrophages. In this context, Ca2+-influx may be
necessary for the activity of PKCα, which is preferentially localized
at the leading edge (53).
CHEMOTACTIC AND PHAGOCYTIC RESPONSES OF
MACROPHAGES TO EXTRACELLULAR ATP
Macrophages and other cells of myeloid lineage respond at three
basic levels to extracellular ATP gradients. First, they migrate
toward increasing ATP concentrations; second, they use the ATP
gradients emanating from dying cells as a “find-me” signal to
locate and phagocytose the cell corpse; and third, at high con-
centrations of ATP, macrophages respond by robust secretion of
proinflammatory cytokines.
Chemotactic responses to ATP were first convincingly demon-
strated using cultured microglial cells. Extracellular ATP at micro-
molar concentrations induced pronounced membrane ruffling,
chemokinesis, and chemotaxis (14). This aspect of purinergic
response was not confined to ATP gradients emanating from a
distant site, indicating ATP acted on cells in an autocrine manner.
Indeed, migrating human neutrophils release ATP from their lead-
ing edges to amplify and steer their migration using an autocrine
feedback loop that involves multiple types of purinergic receptors
(54). In macrophages, the chemotactic response to C5a also uti-
lizes an“autocrine purinergic loop”that involves the release of ATP
at the leading edge and activation of multiple purinergic receptors
(5). In asthmatic airway inflammation, ATP-induced chemotaxis
appears to play a critical role in eosinophil and dendritic cell
infiltration (55).
The analysis of dendritic cell responses to ATP clearly demon-
strates that the chemotactic response to ATP is mechanistically
dissociated from other cellular effects of ATP such as secretion
of proinflammatory cytokines (16). However, the ATP-induced
chemotactic response is intricately connected to the role of
purinergic signaling in the location and phagocytosis of apoptotic
cells. In the central nervous system, damaged neurons release UDP,
which triggers the phagocytic response in neighboring microglial
cells (15) and similar mechanisms are likely at work in other
tissue-resident macrophages. A definitive role for extracellular ATP
as a find-me signal for phagocytes was demonstrated by Elliott et al.
(9). The release of ATP and UTP is dependent on the activation
of caspases and Pannexin 1 during the early stages of apoptosis
and the concentration gradient generated by such release is highly
efficient at recruiting monocytes and macrophages. Whether dif-
ferent macrophage phenotypes migrate differently in response to
ATP gradients has not been explored. Phagocytosis of dying cells
that release ATP serves an anti-inflammatory role, and phago-
cytotic capacity is drastically inhibited in Mox macrophages that
accumulate at the sites of oxidative tissue damage (56). In this con-
text, it would be interesting to know whether alternatively activated
M2 or M2-like macrophages show any significant specialization in
locating dying cells using the ATP gradients.
EXTRACELLULAR ATP AS A TRIGGER FOR
PROINFLAMMATORY CYTOKINE SECRETION AND
PYROPTOSIS
Sustained exposure to relatively high concentrations of ATP has
been shown to be a critical signal for the secretion of proinflam-
matory cytokines, such as IL-1β and IL-18. The unconventional
secretion of these cytokines is accomplished through proteolytic
processing by caspase-1. The activation of caspase-1 is regulated
by large multimeric complexes called inflammasomes and the acti-
vation of one such inflammasome, the NLRP3 inflammasome, is
highly sensitive to the presence of extracellular ATP. Early evidence
for ATP-induced maturation of IL-1β came from studies involving
apoptosis of peritoneal exudate cells when exposed to high con-
centrations of extracellular ATP. This form of apoptosis, which we
now refer to as pyroptosis, was accompanied by proteolytic pro-
cessing and release of IL-1β (57), and was especially pronounced
in LPS-stimulated mouse peritoneal macrophages where exposure
to millimolar concentrations of ATP resulted in rapid processing
and release of IL-1β. It was further demonstrated that exposure to
high concentrations of extracellular K+ prevented the processing
and release of IL-1β (58), suggesting that depletion of intracellular
K+ was essential for ATP-induced IL-1β processing. Subsequent
studies of this phenomenon were greatly facilitated by the isola-
tion of the human monocytic cell line THP-1, which was shown to
be highly sensitive to purinergic stimulation of IL-1β processing.
At least in human monocytes, the purinergic activation of IL-1β
processing and secretion is also accompanied by release of prote-
olytically activated caspase-1 and a commitment to cell death (59).
A study conducted by Dixit and colleagues tested the role
of channel-mediated ATP release by characterizing Pannexin 1-
deficient mice in the context of inflammasome activation (60).
Authors show that the activation of caspase-1 and secretion of
IL-1β in response to a wide variety of stimuli including ATP is
normal in Pannexin-1-deficient macrophages. In contrast, Pan-
nexin 1-deficient thymocytes failed to recruit macrophages after
undergoing apoptosis. Overall, these studies indicate that ATP
released through Pannexin 1 is sufficient to reach extracellular
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concentrations that are of functional relevance to chemotaxis.
However, the activation of caspase-1 typically requires high con-
centrations of ATP that are unlikely to be reached when cytosolic
ATP is released through Pannexin 1. The role of vesicular release
of ATP in the autocrine activation of inflammasome has not yet
been ruled out and that may hold the key to reconcile these stud-
ies. A key component of vesicular ATP release is the vesicular
nucleotide transporter VNUT (also known as SLC17A9), which
is responsible for the accumulation of ATP into secretory vesi-
cles (61). The human monocytic cell line THP-1 has been shown
to express VNUT, which mediates the rapid secretion of ATP in
response to LPS treatment (62). The function of vesicular ATP
secretion in mouse macrophages and its physiological significance
have not been reported yet. It is also not clear whether M1 and
M2 macrophages exhibit mechanistic and functional differences
in ATP release mechanisms.
The mechanisms through which activated caspase-1 and IL-
1β are secreted have remained unclear but there is evidence
for the involvement of Ca2+-influx elicited by ATP (19). Inter-
estingly, although high concentrations of ATP are required for
caspase-1 activation, low concentrations of ATP (10µM) or UTP
(10µM) are sufficient to induce oscillations in intracellular Ca2+
and increased transcription of the proinflammatory cytokine IL-6
(45). An autocrine role for ATP-induced activation of inflam-
masome has also been suggested in the case of primary human
monocytes that are stimulated by danger-associated uric acid.
According to this model, the activation of inflammasome is depen-
dent upon the initial release of ATP, which then acts on purinergic
receptors in an autocrine manner. Whether such secretion results
in local ATP concentrations that are high enough to activate
the inflammasomes is not clear (11). In addition to the regula-
tion of IL-1β and IL-18 secretion, ATP has also been shown to
regulate the secretion of lysosomal cathepsins (27). These pro-
teases are involved in the degradation of extracellular matrix and
can result in auto-inflammatory tissue damage. Recently, ATP
was shown to potentiate the release of IFNβ in LPS-stimulated
macrophages (30).
With respect to macrophage phenotypes, a recent study pro-
vided evidence that inflammatory M1 macrophages are more
sensitive to ATP and more efficient at ATP-induced IL-1β release
when compared to M2 macrophages (31). While the physiological
significance of these findings remains to be elucidated, this study
provides the initial exploratory foray into these outstanding ques-
tions pertaining to how macrophage polarization fine-tunes the
sensitivity to the purinergic microenvironment.
THE ATP METABOLITE ADENOSINE REGULATES THE
RESOLUTION OF INFLAMMATION
Many cells express membrane-bound ectonucleotidases that con-
vert the extracellular ATP and ADP to adenosine. A common
pathway involves the conversion of ATP and ADP to AMP by
CD39 and subsequent conversion of AMP to adenosine by CD73.
These enzymatic biochemical conversions have potent implica-
tions for the termination of inflammatory response due to the
reduction in ATP levels. More significantly, adenosine serves as
a ligand for G-protein coupled adenosine receptors or P1 recep-
tors on myeloid cells (Table 1). The four P1 adenosine receptors
(A1, A2A, A2B, and A3) transmit a “calm down” signal that may
orchestrate the resolution of inflammation, a process conceptually
different from anti-inflammatory signals that restrain the initia-
tion of inflammatory process by preventing the recruitment and
activation of immunocytes. Pertinently, extracellular adenosine
has been shown to augment the polarization of macrophages
toward the M2 phenotype (63).
Early studies showed that adenosine inhibited the secretion of
TNFα, IL-6, and IL-8 by LPS-activated human monocytes (64).
Subsequently, it was shown that the adenosine receptor A3 plays
a major role in downregulating the synthesis of proinflamma-
tory cytokines in monocytes and macrophages in response to
extracellular adenosine (65, 66). Synthetic agonists of A3 adeno-
sine receptor have been shown to have potent therapeutic effects
in various mouse models of rheumatoid arthritis (67). A simi-
lar role for the A2A adenosine receptor has also been reported.
Mice deficient in the A2A receptor show extensive tissue damage
and prolonged inflammation to sub-threshold doses of inflamma-
tory stimuli in three different disease models (68). In the context
of infectious diseases and polymicrobial sepsis, A2A receptors
are required for the control of IL-10 production by alternatively
activated macrophages (69). The A2A receptors also play an anti-
inflammatory role in neuroinflammation. The ligation of A2A
receptors on the activated microglia has been shown to retract
their processes and initiate the resolution of inflammation in the
brain (70).
In the case of endotoxin-induced lung injury, the pharma-
cological inhibition or genetic deletion of A2B receptors greatly
exacerbates lung injury. In contrast, the A2B receptor agonist atten-
uates endotoxin-induced lung inflammation (71). The role of A2B
receptors in dampening endotoxin-induced inflammation is evi-
dent in mouse models of polymicrobial sepsis. Deletion of A2B
receptors greatly increases the mortality of mice from cecal ligation
and puncture-induced sepsis (72). The A2B-deficient mice showed
increased levels of proinflammatory cytokines and chemokines in
the serum, coincident with augmented activation of NFκB and
p38 in the spleen.
In summary, the adenosine receptors provide crucial informa-
tion to monocytes and macrophages and calibrate their response
to the complex mix of purinergic stimuli in the inflammatory
microenvironment (73). In this context, the ratio of ATP and
adenosine may provide the crucial cues necessary for the polariza-
tion of macrophages toward the M2 phenotype induced by IL-4.
The role of A2A and A2B receptors to augment this process of M2
polarization has been illuminated (63) but surprisingly, a recent
study shows that adenosine may control this process independent
of IL-4 (74). Similarly, a recent study provides evidence suggesting
a role for adenosine in IL-10-induced STAT3 activation in alter-
natively activated phenotype termed M2c (75). Manipulation of
ATP and adenosine levels in the tissue microenvironment is thus
likely to emerge as a potent mechanism to guide the plasticity of
macrophages and holds clinical potential for therapeutic interven-
tion. This concept may find traction in a large variety of diseases
where inflammation plays a major pathological role. A recent pre-
clinical study exemplifies the application of this strategy in the
treatment of osteolysis; the authors show that activation of A2A
receptors prevents wear-induced osteolysis (76).
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EXTRACELLULAR ATP PLAYS A PROMINENT ROLE IN
INFLAMMATORY DISEASES
Some of the earliest evidence indicating a role for extracellu-
lar ATP in monocyte and macrophage function came from the
findings that the cells of the myeloid lineage exhibit rapid eleva-
tions in intracellular Ca2+ when treated with micromolar amounts
of ATP (13). The in vivo significance of this finding was further
highlighted by the studies of Bertics and colleagues who showed
that LPS-induced activation of macrophages was greatly enhanced
by extracellular ATP (77) and that mice treated with the adenine
nucleotide analog 2-methylthio-ATP were protected from endo-
toxic shock (78). Subsequent studies indicated a potent role for
purinergic signals in controlling the inflammatory gene expression
in response to LPS stimulation (79). The extensive contribution
of purinergic signaling in inflammatory processes has now been
established in a wide variety of pathologies (2), some of which are
outlined below.
The tissue-resident macrophages of the central nervous sys-
tem, the microglia, have been shown to be especially sensitive to
extracellular ATP. In vitro studies with cultured microglia revealed
that extracellular ATP and ADP stimulate chemotaxis and mor-
phological changes (14). Local trauma in the brain, which results
in cell death, is thought to increase the extracellular levels of
ATP significantly and elegant studies using multiphoton imaging
have demonstrated that microglia respond rapidly to local injury
through dynamic changes in their morphology. The convergence
of microglial processes at the injury site could also be stimulated
by local injection of ATP and this response was demonstrated to
be highly sensitive to the presence of ATP-hydrolyzing enzymes
and blockers of purinergic receptors (80).
In the lungs of asthmatic patients, allergic challenges cause
rapid accumulation of ATP and this has been modeled success-
fully in mice using experimentally induced asthma (55). Interest-
ingly, hydrolysis of ATP in the airways through the application
of apyrase greatly reduces eosinophil infiltration, production of
Th2 cytokines, and bronchial hyper-reactivity. Corollary experi-
ments show that exogenous ATP potentiates airway inflammation
(55) and similar findings have demonstrated a role for purinergic
signals in cigarette smoke-induced inflammation and emphysema
(25). The significance of purinergic signals in allergic reactions
is also evident in the skin. The accumulation of ATP in response
to contact allergans is critical for the production of inflammatory
cytokines by the myeloid cells and the subsequent sensitization
process (23). Accumulation of ATP has also been observed in
the ascites of patients and mice undergoing GVHD. In mice, the
severity of GVHD is greatly reduced by neutralizing the ATP
or by blocking purinergic signaling (24). Furthermore, recent
studies have also implicated extracellular ATP in the develop-
ment of intestinal inflammation in patients with Crohn’s disease.
In corresponding mouse models, blocking purinergic signaling
greatly reduces the activation of intestinal mast cells and thereby
blocks the subsequent rise in proinflammatory cytokines and
leukotrienes (26).
In summary, studies in human beings and mice provide con-
clusive evidence that purinergic signals play a major role in inflam-
mation and tissue injury. Purinergic receptors are expressed ubiq-
uitously and a comprehensive understanding of how purinergic
signals influence the physiology and pathology is still in rudimen-
tary stages. Purinergic control of macrophage function promises
to play a central role in these processes and understanding the
effects of purinergic signals on macrophage function provides an
immediate window toward therapeutic intervention.
CONCLUDING REMARKS
Our understanding of the fundamental role played by purinergic
and Ca2+ signaling in macrophage activity is increasing rapidly but
the signaling mechanisms that drive specific cellular outputs still
remain largely enigmatic. The close coupling of purinergic stimu-
lation and Ca2+ influx suggests that the purinergic receptors, Orai
channels, and TRP channels function in a co-ordinated network
that responds rapidly to the changes in the inflammatory microen-
vironment. By virtue of being excellent drug targets, purinergic
G-protein coupled receptors and ion channels offer an entic-
ing pharmacological path to shape the plasticity of macrophage
function in various diseases. To make this a reality, we will
need to develop experimental models where the influence of the
purinergic microenvironment and the resulting Ca2+-dynamics
in macrophages can be interrogated in situ. All indications are that
we have only just scratched the surface in this exciting area of
innate immunity.
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